ABCC1 and cancer: Another hallmark of CSCs that distinguishes them from most other cancer cells is that they exhibit a multi-drug resistance phenotype by overexpression of drug efflux transporters on the cell surface, including ABCB1/P-gp, ABCC1/MRP1, and ABCG2/BCRP6.